Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa
The Journal of Organic Chemistry · 2025
DOI: 10.1021/acs.joc.5c00476 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Organic Chemistry, 2025. Verfasst von Cliff Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States. Hauptthemen laut MEDLINE: Iridium, Levodopa, Boron Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Natural Science, Michigan State University, Michigan State University Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.
- Department of Radiology, Michigan State University, 846 Service Road, East Lansing, Michigan 48824, United States.
- Institute for Quantitative Health Science & Engineering, 775 Woodlot Drive, East Lansing, Michigan 48824, United States.
ORCID-Profile: Jinda Fan, Robert E Maleczka
Förderung
- College of Natural Science, Michigan State University
- Michigan State University Research Foundation
Zitieren
APA
Yang, C., Fan, J., & Maleczka, R. E. (2025). Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa. The Journal of Organic Chemistry. https://doi.org/10.1021/acs.joc.5c00476
Vancouver
Yang C, Fan J, Maleczka RE. Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa. The Journal of Organic Chemistry. 2025. doi:10.1021/acs.joc.5c00476
BibTeX
@article{Yang2025,
author = {Yang, Cliff and Fan, Jinda and Maleczka, Robert E},
title = {Protective Group-Dependent Iridium-Catalyzed CH Borylations of Levodopa},
journal = {The Journal of Organic Chemistry},
year = {2025},
doi = {10.1021/acs.joc.5c00476}
}
EUVIMED